Federal Awards · INNOVITAL SYSTEMS INC · Award

DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER S…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
HT942524C0010
Contractor
INNOVITAL SYSTEMS INC
Awarding agency
Department of Defense
Sub-agency / office
Defense Health Agency
Award amount
$1,300,000
Period of performance
Jan 5, 2024 – May 4, 2027
NAICS
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
PSC AN12
Place of performance
BELTSVILLE, MD, 207051000, USA
Competition
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES · Set-aside: SMALL BUSINESS SET ASIDE - TOTAL · 4 offers
Pricing
FIRM FIXED PRICE
Financial breakdown
Current value $1,300,000 · Obligated $1,300,000 · Potential value $1,300,000 · Latest action obligation $0

Public award description

DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION.

Most recent · Modification P00004 · Jun 22, 2026 · $0 action obligation · AGITUBE (NOW CLR): FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS · HT942524C0010

Modification P00003 · Jun 11, 2026 · $0 action obligation · AGITUBE (NOW CLR): FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS · HT942524C0010

Modification P00002 · Sep 29, 2025 · $0 action obligation · AGITUBE (NOW CLR): FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS · HT942524C0010

Modification P00001 · Jun 27, 2025 · $0 action obligation · DHA SEQUENTIAL PHASE II TITLED: AGITUBE (NOW CLR), FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS · HT942524C0010

Modification 0 · Dec 12, 2023 · $1,300,000 action obligation · DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION. · HT942524C0010

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. Click Gemini to copy the research question when your browser allows, or use Copy question.